Facebook Twitter LinkedIn Instagram Email Printer Google Plus

John Rudoy, PhD

Director, Marsh & McLennan Advantage, Healthcare

Cell and gene therapies represent both sides of modern healthcare — the hopeful and the concerning. They advance the science of medicine, treating and curing diseases that we struggled to address in the past.

Director, Marsh & McLennan Advantage, Healthcare
Pharmacy Clinical Director of Marsh McLennan Agency
Senior Vice President at Guy Carpenter
National Practice Leader at Marsh McLennan Agency

Winning back talent is becoming the fight of our lives.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Burnout is a syndrome that arises when the demands of work exceed the resources that you're offered to manage them — it's an organizational problem.

Director, Marsh & McLennan Advantage, Healthcare
Chief Medical Officer, Schwartz Center for Compassionate Healthcare

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Former Engagement Manager, Oliver Wyman

A Guide to Economic Recovery for Health System CFOs

How prioritizing long-term organizational changes immediately will ensure stability post-crisis.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare
Global Head, Provider, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

It’s senior leadership’s job — including board members — to mitigate the effects of this pandemic.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Oliver Wyman's 2018 Consumer Survey explores healthcare's supply and demand disconnect.

Director, Marsh & McLennan Advantage, Healthcare
Global Leader, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Former Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe